Overview

DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris

Status:
Unknown status
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the efficacy and safety of traditional Chinese medicine DaZhu Rhodiola Rosea Capsule for treatment of coronary artery disease by observing angina symptoms, exercise capacity, and quality of life.
Phase:
Phase 4
Details
Lead Sponsor:
Beijing Anzhen Hospital
Collaborator:
Jiangsu Kangyuan Pharmaceutical Co. Ltd